Salmeterol xinafoate vs albuterol in asthma: was race a factor?
Olopade
C O
CO
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000208:ethnology*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D006801:Humans; D044469:Racial Groups; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000420:Albuterol